October 14, 2010

An open letter from Sophie Delaunay, Executive Director of MSF-USA, urging the U.S. to stop supplying nutritionally substandard food to malnourished children in developing countries.

July 21, 2010

Innovation and Access for Neglected Diseases: The Experience of Médecins Sans Frontières

U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) Hearing

Oral Statement of
Suerie Moon
Board of Directors
Doctors Without Borders/Médecins Sans Frontières - USA
July 21, 2010, 10am
430 Dirksen Senate Office Building

Thank you, Chairperson Harkin, Ranking Member Enzi, and the Committee.

March 18, 2010

NY Times Lettter-to-the-Editor on MSF concerns that a provision in proposed U.S. health care legislation will allow pharmaceutical companies to extend monopolies on high-priced, cutting-edge medicines.

March 03, 2010

MSF testified at a hearing before the US Trade Representative about the effect of US trade and intellectual property pressures on global health policy and efforts to expand access to affordable medicines in developing countries.

January 11, 2010

Doctors Without Borders is urging law makers to revise a provision in the U.S. health care legislation that would essentially allow pharmaceutical companies to extend their monopolies on a rapidly expanding and high-priced brand of drugs known as biologics. Biologics--medicines derived from living cells--hold great promise for new vaccines and medicines. Unfortunately, the biologics provision in the current legislation will create a massive barrier to developing generic versions of these cutting-edge drugs.